Tim’s investment focus has been shaped by his broad business experience with creating, growing, and financing entrepreneurial firms. His investments target capital-efficient companies in medical technology, health IT and services that redefine efficient models for care delivery and improve access to care. Tim has led investments and held board seats in more than a dozen portfolio companies during his tenure with Arboretum. Exited investments include Accuri, HealthMedia, Inogen (Nasdaq: INGN) and IntelliCyt, each generating between four and ten times Arboretum’s investment. Inogen, which went public in 2014, currently has a market capitalization in excess of $1 billion.
From 1999 to 2002, he helped establish the Zell Lurie Institute for Entrepreneurial Studies at the University of Michigan, serving as its Managing Director. The Institute has been consistently ranked as one of the top three entrepreneurship programs in the country. During his tenure at Michigan, he also directed the activities of the Wolverine Venture Fund, the Institute’s venture capital fund focusing on early-stage life science and technology investments. Prior to Michigan, Tim was a manager in the investment banking practice at Plante Moran Corporate Finance and served as a management consultant at Industrial Economics, Inc. in Cambridge, MA.